Epidemiology, Clinical Features, and Antimicrobial Resistance of InvasiveEscherichia ColiDisease in Patients Admitted in Tertiary Care Hospitals

Author:

Doua Joachim1ORCID,Geurtsen Jeroen2,Rodriguez-Baño Jesus3456,Cornely Oliver A78910,Go Oscar11,Gomila-Grange Aina1213,Kirby Andrew14,Hermans Peter15,Gori Andrea16,Zuccaro Valentina17,Gravenstein Stefan18,Bonten Marc19,Poolman Jan2,Sarnecki Michal20

Affiliation:

1. Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica , Beerse , Belgium

2. Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V. , Leiden , The Netherlands

3. Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena , Seville , Spain

4. Department of Medicine, University of Sevilla , Seville , Spain

5. Biomedicine Institute of Sevilla/CSIC , Seville , Spain

6. CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III , Madrid , Spain

7. Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne , Cologne , Germany

8. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) , Cologne , Germany

9. Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne , Cologne , Germany

10. German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne , Cologne , Germany

11. Janssen Research & Development , Raritan, New Jersey , USA

12. Infectious Diseases Department, Hospital Universitari de Bellvitge, Carrer de la Feixa Llarga , s/n, 08907 L’Hospitalet de Llobregat, Barcelona , Spain

13. Infectious Diseases Department, Hospital Parc Taulí de Sabadell, Parc Tauli , Barcelona , Spain

14. Leeds Institute of Medical Research, The University of Leeds, Old Medical School, Leeds General Infirmary , Leeds, West Yorkshire , United Kingdom

15. Julius Center for Health Sciences and Primary Care University Medical Center, Utrecht University , Utrecht , The Netherlands

16. Department of Pathophysiology and Transplantation, University of Milan , Milan , Italy

17. Infectious Diseases Department, IRCCS Policlinico San Matteo Foundation, University of Pavia , Pavia, Lombardy , Italy

18. Department of Medicine, Alpert Medical School of Brown University , Providence, Rhode Island , USA

19. Julius Center for Health Sciences and Primary Care, University Medical Center , Utrecht , The Netherlands

20. Clinical Development, Janssen Vaccines , Bern , Switzerland

Abstract

AbstractBackgroundInvasive Escherichia coli disease (IED), including bloodstream infection, sepsis, and septic shock, can lead to high hospitalization and mortality rates. This multinational study describes the clinical profile of patients with IED in tertiary care hospitals.MethodsWe applied clinical criteria of systemic inflammatory response syndrome (SIRS), sepsis, or septic shock to patients hospitalized with culture-confirmed E coli from urine or a presumed sterile site. We assessed a proposed clinical case definition against physician diagnoses.ResultsMost patients with IED (N = 902) were adults aged ≥60 years (76.5%); 51.9%, 25.1%, and 23.0% of cases were community-acquired (CA), hospital-acquired (HA), and healthcare-associated (HCA), respectively. The urinary tract was the most common source of infection (52.3%). Systemic inflammatory response syndrome, sepsis, and septic shock were identified in 77.4%, 65.3%, and 14.1% of patients, respectively. Patients >60 years were more likely to exhibit organ dysfunction than those ≤60 years; this trend was not observed for SIRS. The case-fatality rate (CFR) was 20.0% (60–75 years, 21.5%; ≥75 years, 22.2%), with an increase across IED acquisition settings (HA, 28.3%; HCA, 21.7%; CA, 15.2%). Noticeably, 77.8% of patients initiated antibiotic use on the day of culture sample collection. A total of 65.6% and 40.8% of E coli isolates were resistant to ≥1 agent in ≥1 or ≥2 drug class(es). A 96.1% agreement was seen between the proposed clinical case definition and physician's diagnoses of IED.ConclusionsThis study contributes valuable, real-world data about IED severity. An accepted case definition could promote timely and accurate diagnosis of IED and inform the development of novel preventative strategies.

Funder

Janssen Research & Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3